Overview of Emerging Technologies: Opioids with Abuse-Deterrent Properties and Claims


Science & Innovation Theater Webinar 

Recorded on October 7, 2015 

Sponsored by Purdue Pharma L.P. 


This session will provide an overview of the evolving technology being used to impart abuse deterrence to opioid analgesics that are currently marketed in the U.S. or are in development. It includes 1) a review of the rationale for developing opioid analgesic drug products that deter particular methods of abuse, 2) highlights of the federal strategy to reduce both the prevalence and consequences of opioid analgesic abuse, and 3) information to help locate FDA-approved abuse-deterrence claims within a drug product’s label.


J. David Haddox, DDS, MD, DABPM, MRO
Vice President, Health Policy
Purdue Pharma L.P.

Purdue Logo 

This webinar is sponsored, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinars and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.